|

Ademetionine Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Phenomen Pharma1

Indications

  • Fatty Liver, Alcoholic1
  • Nonalcoholic Fatty Liver (NAFL)1
  • Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)1
  • Nonalcoholic Fatty Liver Disease (NAFLD)1
  • Hepatomegaly1

Other1 trial

Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.